Identity
HGNC
LOCATION
4p16.1
LOCUSID
ALIAS
GLUT9,GLUTX,UAQTL2,URATv1
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 56606
MIM: 606142
HGNC: 13446
Ensembl: ENSG00000109667
Variants:
dbSNP: 56606
ClinVar: 56606
TCGA: ENSG00000109667
COSMIC: SLC2A9
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000109667 | ENST00000264784 | Q9NRM0 |
| ENSG00000109667 | ENST00000309065 | Q9NRM0 |
| ENSG00000109667 | ENST00000506583 | Q9NRM0 |
| ENSG00000109667 | ENST00000513129 | D6REK5 |
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 38150892 | 2024 | Raised CK and acute kidney injury following intense exercise in three patients with a history of exercise intolerance due to homozygous mutations in SLC2A9. | 0 |
| 38150892 | 2024 | Raised CK and acute kidney injury following intense exercise in three patients with a history of exercise intolerance due to homozygous mutations in SLC2A9. | 0 |
| 36736875 | 2023 | The in-silico evaluation of important GLUT9 residue for uric acid transport based on renal hypouricemia type 2. | 0 |
| 37176161 | 2023 | Pathogenic Variants of SLC22A12 (URAT1) and SLC2A9 (GLUT9) in Spanish Patients with Renal Hypouricemia: Founder Effect of SLC2A9 Variant c.374C>T; p.(T125M). | 2 |
| 37308567 | 2023 | GLUT9 as a potential drug target for chronic kidney disease: Drug target validation by a Mendelian randomization study. | 0 |
| 36736875 | 2023 | The in-silico evaluation of important GLUT9 residue for uric acid transport based on renal hypouricemia type 2. | 0 |
| 37176161 | 2023 | Pathogenic Variants of SLC22A12 (URAT1) and SLC2A9 (GLUT9) in Spanish Patients with Renal Hypouricemia: Founder Effect of SLC2A9 Variant c.374C>T; p.(T125M). | 2 |
| 37308567 | 2023 | GLUT9 as a potential drug target for chronic kidney disease: Drug target validation by a Mendelian randomization study. | 0 |
| 35203284 | 2022 | Glucose Transporter 9 (GLUT9) Plays an Important Role in the Placental Uric Acid Transport System. | 4 |
| 36006548 | 2022 | The regulation effect of GLUT9/SLC2A9 on intrahepatic uric acid level and metabolic associated fatty liver disease. | 3 |
| 35203284 | 2022 | Glucose Transporter 9 (GLUT9) Plays an Important Role in the Placental Uric Acid Transport System. | 4 |
| 36006548 | 2022 | The regulation effect of GLUT9/SLC2A9 on intrahepatic uric acid level and metabolic associated fatty liver disease. | 3 |
| 32778763 | 2021 | Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects. | 6 |
| 32806975 | 2021 | The haplotype of SLC2A9_rs3733591, PKD2_rs2725220 and ABCG2_rs2231142 increases the hyperuricaemia risk and alcohol, chicken and processed meat intakes and smoking interact with its risk. | 7 |
| 34716863 | 2021 | The effects of hyperuricemia on endothelial cells are mediated via GLUT9 and the JAK2/STAT3 pathway. | 4 |
Citation
Dessen P
SLC2A9 (solute carrier family 2 member 9)
Atlas Genet Cytogenet Oncol Haematol. 2015-06-01
Online version: http://atlasgeneticsoncology.org/gene/55281/slc2a9-(solute-carrier-family-2-member-9)
